In Vitro Diagnostics Market Size – By Product Type (Reagents and Kits, Instruments and Software and Services), By Technology (Immunoassay/Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation and Hemostasis, Urinalysis, Point-of-Care Testing (POCT), and Others), By Application (Infectious Diseases, Diabetes, Oncology/Cancer, Cardiology, Autoimmune Diseases, Nephrology, Drug Testing, and Others), By End-user (Hospitals, Laboratories, Academic & Research Institutes, Point-of-Care Testing Centers, Home Care Settings and Others) & Region – Global Forecasts 2024 - 2034
- PUBLISHED ON
- 2024-10-16
- NO OF PAGES
- 330
- CATEGORY
- Healthcare & Life Sciences
Market Overview
The In Vitro Diagnostics market report is predicted to develop at a compound annual growth rate (CAGR) of 4.3% from 2024 to 2034, when global In Vitro Diagnostics market forecast size is projected to reach USD 125.43 Billion in 2034, based on an average growth pattern. The global In Vitro Diagnostics market revenue is estimated to reach a value of USD 75.72 Billion in 2024.
SOURCE: We Market Research
The Global In
Vitro Diagnostics (IVD) market analysis refers to the sector of medical devices
and equipment used to perform diagnostic tests on samples taken from the human
body, such as blood, urine, tissue, or other bodily fluids. These tests are
conducted outside the human body, in laboratories or at the point of care, and
are designed to detect diseases, conditions, infections, and overall health
status.
The purpose of
IVDs is to aid in diagnosing medical conditions, monitoring disease
progression, predicting treatment response, and guiding therapeutic decisions.
The market encompasses a wide range of products, including reagents,
instruments, software, and services, utilizing various technologies like
immunoassays, molecular diagnostics, clinical chemistry, microbiology,
hematology, and more. IVDs are used across multiple applications, including
infectious diseases, cancer, cardiology, autoimmune disorders, and more, in
diverse settings such as hospitals, clinical laboratories, research
institutions, and home healthcare. The IVD market plays a critical role in
healthcare by enabling early diagnosis, disease prevention, and personalized
treatment strategies, thus improving patient outcomes and reducing healthcare
costs.
Market Scope
|
Report Attributes |
Description |
|
Market Size in 2024 |
USD 75.72 Billion |
|
Market
Forecast in 2034 |
USD 125.43 Billion |
|
CAGR % 2024-2034 |
4.3% |
|
Base
Year |
2023 |
|
Historic Data |
2016-2022 |
|
Forecast
Period |
2024-2034 |
|
Report USP
|
Production,
Consumption, company share, company heatmap, company production capacity,
growth factors and more |
|
Segments
Covered |
By Product
Type, By Technology, By Application, By End-user and By Region |
|
Regional Scope |
North America,
Europe, APAC, South America and Middle East and Africa |
|
Country
Scope |
U.S.; Canada;
U.K.; Germany; France; Italy; Spain; Benelux; Nordic Countries; Russia;
China; India; Japan; South Korea; Australia; Indonesia; Thailand; Mexico;
Brazil; Argentina; Saudi Arabia; UAE; Egypt; South Africa; Nigeria |
Market: Dynamics & Restrains
Global In Vitro Diagnostics Market Opportunity:
We Market
Research: Dashboard
Our marketing
platform offers a comprehensive dashboard that provides clients with valuable
insights into global In Vitro Diagnostics market trends over the years.
Included below is a sample image of our dashboard, and specific PDF logins will
be furnished to grant access to this insightful tool.
In Vitro Diagnostics Market Segmentation
Market- By Product Type Analysis
By product type, the market is categories into Reagents and Kits, Instruments and Software and Services. Reagents and Kits dominate the market with the largest share, accounting for over 65% of the market in 2023. Reagents and kits are consumables that need to be regularly purchased for diagnostic tests, which drives consistent demand in both clinical laboratories and point-of-care settings. They are used in various diagnostic procedures, including molecular diagnostics, immunoassays, microbiology, and clinical chemistry. Innovations in molecular diagnostic techniques, such as PCR and NGS, have increased the demand for specific reagents and kits that provide high sensitivity and accuracy.
The
following segments are part of an in-depth analysis of the global In Vitro
Diagnostics market:
|
Market Segments |
|
|
By Product
Type |
·
Reagents and Kits ·
Instruments ·
Software and Services |
|
By
Technology |
·
Immunoassay/Immunochemistry ·
Clinical Chemistry ·
Molecular Diagnostics ·
Hematology ·
Microbiology ·
Coagulation and Hemostasis ·
Urinalysis ·
Point-of-Care Testing (POCT) ·
Others |
|
By Application |
·
Infectious Diseases ·
Diabetes ·
Oncology/Cancer ·
Cardiology ·
Autoimmune Diseases ·
Nephrology ·
Drug Testing ·
Others |
|
By
End-user |
·
Hospitals ·
Laboratories ·
Academic & Research Institutes ·
Point-of-Care Testing Centers ·
Home Care Settings ·
Others |
In Vitro Diagnostics Industry: Regional Analysis
North America Market Forecast
North America dominates the global market, accounting for around 38% of the global In Vitro Diagnostics market share in 2023. The United States and Canada are significant contributors to the IVD market in this region. The presence of a well-established healthcare system and advanced laboratory facilities promotes the adoption of innovative IVD technologies. The growing prevalence of chronic and infectious diseases in the U.S. and Canada fuels the demand for diagnostic testing. Major players like Abbott Laboratories, Roche Diagnostics, and Siemens Healthineers have a significant presence in this region, contributing to its market leadership.
Europe Market Statistics
The European
Union's regulatory framework encourages the development and approval of new IVD
products, facilitating market entry for innovative solutions. The rise in
personalized and precision medicine is driving the adoption of advanced
molecular diagnostics and genetic testing. An increase in the aging population
in Europe leads to a higher demand for diagnostic tests for chronic diseases.
Companies like QIAGEN and BioMérieux are key players in the European IVD
market, focusing on molecular diagnostics and infectious disease testing.
Asia Pacific Market Forecasts
Increasing
healthcare spending and investments in laboratory infrastructure across
countries like China, India, and Japan are driving in vitro diagnostics market
growth. The rising prevalence of chronic diseases, such as diabetes and cancer,
necessitates advanced diagnostic testing. Growing awareness of the importance
of early diagnosis and preventive healthcare is boosting the demand for IVD
products. Companies such as Siemens Healthineers and Abbott Laboratories are
expanding their presence in this region, leveraging the growing demand for
advanced diagnostic solutions.
Middle East & Africa Market Statistics
Countries in the
Middle East, such as the UAE and Saudi Arabia, are investing heavily in
healthcare infrastructure, leading to growth in the IVD market. The rising
incidence of infectious diseases in some African countries drives demand for
diagnostic testing. Despite growth potential, challenges such as limited
healthcare infrastructure and high costs can hinder market expansion in some
areas.
Latin America Market Statistics
Investments in
healthcare infrastructure and diagnostic capabilities in countries like Brazil
and Mexico are driving market growth. There is a growing demand for
point-of-care testing solutions due to the need for rapid diagnostics in remote
areas. Market growth is tempered by regulatory challenges and the need for
affordable diagnostic solutions.
Key Market Players
The In Vitro Diagnostics Market is dominated by a few large companies, such as
·
Roche Diagnostics
·
Abbott Laboratories
·
Siemens Healthineers
·
Danaher Corporation
·
Thermo Fisher Scientific
·
Bio-Rad Laboratories
·
Qiagen N.V.
·
bioMérieux SA
·
Sysmex Corporation
·
Becton, Dickinson and Company (BD)
·
Hologic, Inc.
·
Ortho Clinical Diagnostics
·
Luminex Corporation
· PerkinElmer, Inc.
1.
Global
In Vitro Diagnostics Market Introduction and Market Overview
1.1. Objectives of the Study
1.2. Global In Vitro Diagnostics
Market Scope and Market Estimation
1.2.1. Global In Vitro Diagnostics Overall
Market Size (US$ Bn), Market CAGR (%), Market forecast (2024 - 2034)
1.2.2. Global In Vitro Diagnostics
Market Revenue Share (%) and Growth Rate (Y-o-Y) from 2019 - 2034
1.3. Market Segmentation
1.3.1. Product Type of Global In Vitro
Diagnostics Market
1.3.2. Technology of Global In Vitro
Diagnostics Market
1.3.3. Application of Global In Vitro
Diagnostics Market
1.3.4. End-user of Global In Vitro
Diagnostics Market
1.3.5. Region of Global In Vitro
Diagnostics Market
2.
Executive Summary
2.1. Demand Side Trends
2.2. Key Market Trends
2.3. Market Demand (US$ Bn) Analysis
2019 – 2023 and Forecast, 2024 – 2034
2.4. Demand and Opportunity
Assessment
2.5. Demand Supply Scenario
2.6. Market Dynamics
2.6.1. Drivers
2.6.2. Limitations
2.6.3. Opportunities
2.6.4. Impact Analysis of Drivers and
Restraints
2.7. Pricing Trends Analysis
2.8. Overview of Technology Developments
2.9. Porter’s Five Forces Analysis
2.9.1. Bargaining Power of Suppliers
2.9.2. Bargaining Power of Buyers
2.9.3. Threat of Substitutes
2.9.4. Threat of New Entrants
2.9.5. Competitive Rivalry
2.10. PEST Analysis
2.10.1. Political Factors
2.10.2. Economic Factors
2.10.3. Social Factors
2.10.4. Technology Factors
2.11. Value Chain / Ecosystem Analysis
2.12. Key Regulation
3.
Global In Vitro Diagnostics
Market Estimates & Historical Trend
Analysis (2019 - 2023)
4.
Global In Vitro Diagnostics
Market Estimates & Forecast Trend
Analysis, by Product Type
4.1. Global In Vitro Diagnostics
Market Revenue (US$ Bn) Estimates and Forecasts, by Product Type, 2019 - 2034
4.1.1. Reagents and Kits
4.1.2. Instruments
4.1.3. Software and Services
5.
Global In Vitro Diagnostics
Market Estimates & Forecast Trend
Analysis, by Technology
5.1. Global In Vitro Diagnostics
Market Revenue (US$ Bn) Estimates and Forecasts, by Technology, 2019 - 2034
5.1.1.Immunoassay/Immunochemistry
5.1.2.Clinical
Chemistry
5.1.3.Molecular
Diagnostics
5.1.4.Hematology
5.1.5.Microbiology
5.1.6.Coagulation
and Hemostasis
5.1.7.Urinalysis
5.1.8.Point-of-Care
Testing (POCT)
5.1.9.Others
6.
Global In Vitro Diagnostics
Market Estimates & Forecast Trend
Analysis, by Application
6.1. Global In Vitro Diagnostics
Market Revenue (US$ Bn) Estimates and Forecasts, by Application, 2019 - 2034
6.1.1.Infectious
Diseases
6.1.2.Diabetes
6.1.3.Oncology/Cancer
6.1.4.Cardiology
6.1.5.Autoimmune
Diseases
6.1.6.Nephrology
6.1.7.Drug Testing
6.1.8.Others
7.
Global In Vitro Diagnostics
Market Estimates & Forecast Trend
Analysis, by End-user
7.1. Global In Vitro Diagnostics
Market Revenue (US$ Bn) Estimates and Forecasts, by End-user, 2019 - 2034
7.1.1.Hospitals
7.1.2.Laboratories
7.1.3.Academic
& Research Institutes
7.1.4.Point-of-Care
Testing Centers
7.1.5.Home
Care Settings
7.1.6.Others
8.
Global In Vitro Diagnostics
Market Estimates & Forecast Trend
Analysis, by Region
8.1. Global In Vitro Diagnostics
Market Revenue (US$ Bn) Estimates and Forecasts, by Region, 2019 - 2034
8.1.1. North America
8.1.2. Eastern Europe
8.1.3. Western Europe
8.1.4. Asia Pacific
8.1.5. Middle East & Africa
8.1.6. Latin America
9.
North
America In Vitro Diagnostics Market: Estimates & Forecast Trend Analysis
9.1.
North
America In Vitro Diagnostics Market Assessments & Key Findings
9.1.1. North America In Vitro
Diagnostics Market Introduction
9.1.2. North America In Vitro
Diagnostics Market Size Estimates and Forecast (US$ Billion) (2019 - 2034)
9.1.2.1. By Product Type
9.1.2.2. By Technology
9.1.2.3. By Application
9.1.2.4. By End-user
9.1.2.5. By Country
9.1.2.5.1. The U.S.
9.1.2.5.2. Canada
9.1.2.5.3. Mexico
10. Western Europe In
Vitro Diagnostics Market: Estimates
& Forecast Trend Analysis
10.1. Western Europe In Vitro
Diagnostics Market Assessments & Key Findings
10.1.1. Western Europe In Vitro
Diagnostics Market Introduction
10.1.2. Western Europe In Vitro
Diagnostics Market Size Estimates and Forecast (US$ Billion) (2019 - 2034)
10.1.2.1. By Product Type
10.1.2.2. By Technology
10.1.2.3. By Application
10.1.2.4. By End-user
10.1.2.5. By Country
10.1.2.5.1.
Germany
10.1.2.5.2.
Italy
10.1.2.5.3.
U.K.
10.1.2.5.4.
France
10.1.2.5.5.
Spain
10.1.2.5.6.
Benelux
10.1.2.5.7.
Nordics
10.1.2.5.8. Rest
of W. Europe
11. Eastern Europe In
Vitro Diagnostics Market: Estimates
& Forecast Trend Analysis
11.1. Eastern Europe In Vitro
Diagnostics Market Assessments & Key Findings
11.1.1. Eastern Europe In Vitro
Diagnostics Market Introduction
11.1.2. Eastern Europe In Vitro
Diagnostics Market Size Estimates and Forecast (US$ Billion) (2019 - 2034)
11.1.2.1. By Product Type
11.1.2.2. By Technology
11.1.2.3. By Application
11.1.2.4. By End-user
11.1.2.5. By Country
11.1.2.5.1.
Russia
11.1.2.5.2.
Hungary
11.1.2.5.3.
Poland
11.1.2.5.4.
Balkan & Baltics
11.1.2.5.5. Rest of E. Europe
12. Asia Pacific In
Vitro Diagnostics Market: Estimates
& Forecast Trend Analysis
12.1. Asia Pacific Market Assessments
& Key Findings
12.1.1. Asia Pacific In Vitro
Diagnostics Market Introduction
12.1.2. Asia Pacific In Vitro
Diagnostics Market Size Estimates and Forecast (US$ Billion) (2019 - 2034)
12.1.2.1. By Product Type
12.1.2.2. By Technology
12.1.2.3. By Application
12.1.2.4. By End-user
12.1.2.5. By Country
12.1.2.5.1. China
12.1.2.5.2. Japan
12.1.2.5.3. India
12.1.2.5.4. Australia & New Zealand
12.1.2.5.5. South Korea
12.1.2.5.6. ASEAN
12.1.2.5.7. Rest of Asia Pacific
13. Middle East & Africa In
Vitro Diagnostics Market: Estimates
& Forecast Trend Analysis
13.1. Middle East & Africa Market
Assessments & Key Findings
13.1.1. Middle
East & Africa In
Vitro Diagnostics Market Introduction
13.1.2. Middle
East & Africa In
Vitro Diagnostics Market Size Estimates and Forecast (US$ Billion) (2019 - 2034)
13.1.2.1. By Product Type
13.1.2.2. By Technology
13.1.2.3. By Application
13.1.2.4. By End-user
13.1.2.5. By Country
13.1.2.5.1. UAE
13.1.2.5.2. Saudi
Arabia
13.1.2.5.3. Turkey
13.1.2.5.4. South
Africa
13.1.2.5.5. Rest of
MEA
14. Latin America
In Vitro Diagnostics Market: Estimates
& Forecast Trend Analysis
14.1. Latin America Market Assessments
& Key Findings
14.1.1. Latin America In Vitro
Diagnostics Market Introduction
14.1.2. Latin America In Vitro
Diagnostics Market Size Estimates and Forecast (US$ Billion) (2019 - 2034)
14.1.2.1. By Product Type
14.1.2.2. By Technology
14.1.2.3. By Application
14.1.2.4. By End-user
14.1.2.5. By Country
14.1.2.5.1. Brazil
14.1.2.5.2. Argentina
14.1.2.5.3. Colombia
14.1.2.5.4. Rest of
LATAM
15. Country Wise Market:
Introduction
16. Competition Landscape
16.1. Global In Vitro Diagnostics
Market Product Mapping
16.2. Global In Vitro Diagnostics Market
Concentration Analysis, by Leading Players / Innovators / Emerging Players /
New Entrants
16.3. Global In Vitro Diagnostics
Market Tier Structure Analysis
16.4. Global In Vitro Diagnostics
Market Concentration & Company Market Shares (%) Analysis, 2023
17. Company Profiles
17.1. Roche Diagnostics
17.1.1. Company Overview & Key Stats
17.1.2. Financial Performance & KPIs
17.1.3. Product Portfolio
17.1.4. SWOT Analysis
17.1.5. Business Strategy & Recent Developments
* Similar details would be provided
for all the players mentioned below
17.2. Abbott Laboratories
17.3. Siemens
Healthineers
17.4. Danaher Corporation
17.5. Thermo Fisher
Scientific
17.6. Bio-Rad
Laboratories
17.7. Qiagen N.V.
17.8. bioMérieux SA
17.9. Sysmex Corporation
17.10. Becton, Dickinson
and Company (BD)
17.11. Hologic, Inc.
17.12. Ortho Clinical
Diagnostics
17.13. Luminex Corporation
17.14. PerkinElmer, Inc.
17.15. Others
18. Research
Methodology
18.1. External Transportations /
Databases
18.2. Internal Proprietary Database
18.3. Primary Research
18.4. Secondary Research
18.5. Assumptions
18.6. Limitations
18.7. Report FAQs
19. Research
Findings & Conclusion
Quality Assurance Process
- We Market Research’s Quality Assurance program strives to deliver superior value to our clients.
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
- Project kickoff meeting with client
- Conduct frequent client communications
- Form project steering committee
- Assign a senior SR executive as QA Executive
- Conduct internal editorial & quality reviews of project deliverables
- Certify project staff in SR methodologies & standards
- Monitor client satisfaction
- Monitor realized value post-project
Case Study- Automotive Sector
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
Solution
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
Market Estimates and Forecast
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Case Study- ICT Sector
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.
Frequently Asked Questions
What is the market size of In Vitro Diagnostics Market in 2024?
In Vitro Diagnostics Market was valued at USD 75.72 Billion in 2024.
What is the growth rate for the In Vitro Diagnostics Market?
In Vitro Diagnostics Market size will increase at approximate CAGR of 4.3% during the forecasted period.
Which are the top companies operating within the market?
Major companies operating within the market are Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, Danaher Corporation, Thermo Fisher Scientific, Bio-Rad Laboratories, Qiagen N.V., bioMérieux SA, Sysmex Corporation, Becton, Dickinson and Company (BD), Hologic, Inc., Ortho Clinical Diagnostics, Luminex Corporation, PerkinElmer, Inc. and others.
Which region dominates the In Vitro Diagnostics Market?
North America dominates the market with an active share of 38%.
}})
Select a license type that suits your business needs
US $3499
Only Three Thousand Four Hundred Ninety Nine US dollar
- 1 User access
- 15% Additional Free Customization
- Free Unlimited post-sale support
- 100% Service Guarantee until achievement of ROI
US $4499
Only Four Thousand Four Hundred Ninety Nine US dollar
- 5 Users access
- 25% Additional Free Customization
- Access Report summaries for Free
- Guaranteed service
- Dedicated Account Manager
- Discount of 20% on next purchase
- Get personalized market brief from Lead Author
- Printing of Report permitted
- Discount of 20% on next purchase
- 100% Service Guarantee until achievement of ROI
US $5499
Only Five Thousand Four Hundred Ninety Nine US dollar
- Unlimited User Access
- 30% Additional Free Customization
- Exclusive Previews to latest or upcoming reports
- Discount of 30% on next purchase
- 100% Service Guarantee until achievement of ROI